Lantern Pharma (LTRN) Shares Outstanding (Diluted) (2022 - 2026)
Lantern Pharma's Shares Outstanding (Diluted) was 12.42 million in Q2 2026, up 15.2% from 10.78 million a year earlier and up 10.4% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Lantern Pharma came in at 10.9 million, up 1.3% from FY2024.
- Shares Outstanding (Diluted) shows a three-year compound annual growth rate of 0.1% (FY2022 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 10.76 million in FY2024 (-0.7%), 10.84 million in FY2023 (-0.1%) and 10.85 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2022.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for six straight quarters, with growth averaging 2.6% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q2 2026 (growth of 15.2%); the worst was Q1 2024 (a decline of 1.1%).
- Per Business Quant data, LTRN's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 11.25 million (Q1 2026), 10.9 million (Q4 2025) and 10.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Lantern Pharma | 7.95 Mn | -28.21 Mn | - | 12.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.42 Mn |
| Mar 31, 2026 | 11.25 Mn |
| Dec 31, 2025 | 10.90 Mn |
| Sep 30, 2025 | 10.83 Mn |
| Jun 30, 2025 | 10.78 Mn |
| Mar 31, 2025 | 10.78 Mn |
| Dec 31, 2024 | 10.76 Mn |
| Sep 30, 2024 | 10.76 Mn |
| Jun 30, 2024 | 10.76 Mn |
| Mar 31, 2024 | 10.74 Mn |
| Dec 31, 2023 | 10.84 Mn |
| Sep 30, 2023 | 10.86 Mn |
| Jun 30, 2023 | 10.86 Mn |
| Mar 31, 2023 | 10.86 Mn |
| Dec 31, 2022 | 10.85 Mn |
| Sep 30, 2022 | 10.84 Mn |
| Jun 30, 2022 | 10.83 Mn |
API Access
Lantern Pharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();